Implitapide

Implitapide Uses, Dosage, Side Effects, Food Interaction and all others data.

Implitapide is a microsomal triglyceride transfer protein (MTP)-inhibitor.

Implitapide is an inhibitor of microsomal triglyceride transfer protein (MTP), a key enzyme involved in the assembly and release of cholesterol and triglyceride from the liver and intestinal tract. It is being investigated for the treatment of atherosclerosis.

Table Of contents

• Implitapide
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Implitapide
Generic	Implitapide
Implitapide Other Names	Implitapide
Type
Formula	C35H37N3O2
Weight	Average: 531.6872 Monoisotopic: 531.288577443
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

For the treatment of atherosclerosis.

How Implitapide works

MTP mediates triglyceride absorption and chylomicron secretion from the intestine and very-low-density lipoprotein (VLDL) secretion from the liver by linking lipid molecules with apolipoprotein B (apoB). Inhibition of MTP reduces the level of all apoB-containing lipoproteins, including LDL.

Innovators Monograph

You find simplified version here Implitapide